NCT02824016View on ClinicalTrials.gov

Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2020

Conditions
Irradiation; Adverse EffectIrradiation Hypothyroidism
Interventions
BIOLOGICAL

biological sample

T4, thyrotropic-stimulating hormone (TSH) and Thyroglobulin antibody were systematically measured

RADIATION

supraclavicular irradiation

Irradiation of the homolateral supraclavicular area delivering 46 Gy in 23 fractions

Trial Locations (3)

51100

Institut Jean Godinot, Reims

54519

Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy

67000

Centre Paul Strauss, Strasbourg

All Listed Sponsors
lead

Institut Jean-Godinot

OTHER

NCT02824016 - Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation | Biotech Hunter | Biotech Hunter